Researcher index

Authors in the psilocybin and psilocin literature

Search researcher names, inspect publication history, find recurring topics, and create author watch alerts without collecting unverified contact lists.

Senem Merve Fred

73 indexed publications match this author name.

ORCID: 0000-0003-1992-5014
OpenAlex: https://openalex.org/A5068068737

Author watchlist

Create a confirmed email alert for new publications matching this author.

Topics

Depression 27 Receptor Pharmacology 26 Pharmacology 21 Clinical Trial 18 Safety 16 Mechanism of Action 15 Addiction 15 Toxicity 14 Anxiety 13 Brain Imaging 12 Randomized Controlled Trial 12 Observational Study 12

Journals

Journal of Psychopharmacology 7 Drug and Alcohol Dependence 5 Frontiers in Psychiatry 4 Journal of Hepatology 3 Psychedelic Medicine 3 Digestive and Liver Disease 3 Journal of Heterocyclic Chemistry 3 Psychopharmacology 2

Publication history

Psilocybin therapy for adult females with anorexia nervosa: pilot study.The British Journal of Psychiatry · 2026-07-07 α2-Adrenergic receptor modulates 5-HT2A-mediated behavioral effects of MDMA and psilocybin in mice.Molecular Psychiatry · 2026-07-06 Psilocybin-induced neurocardiogenic syncope: a case reportPsychopharmacology · 2026-05-27 Effects of Psilocybin Treatment on Cognitive Effort Avoidance in Major Depressive Disorder and Co-Occurring Alcohol Use DisorderUnknown journal · 2026-05-01 1080 Psilocybin Elicits Non-Linear Night to Night Changes in Sleep Spectral PowerSLEEP · 2026-04-30 SAT-219 Hepatic 5-HT2B receptor antagonism mediates the anti-steatotic and antifibrotic effects of psilocybin in preclinical MASH modelsJournal of Hepatology · 2026-04-30 Integrating the Mystical Experience Questionnaire Into a Broader Psychometric Framework: English Validation of the Psychedelic Experience Scale and Comparison of Psilocybin and LSD Sessions Across Two Controlled SettingsRepository for Publications and Research Data (ETH Zurich) · 2026-04-29 An international mega-analysis of psychedelic drug effects on brain circuit functionNature Medicine · 2026-03-31 Mystical dynamics: renewal, luminous light, and ego disintegration as key features associated with mystical oneness-a psychometric analysis using the PES100 in controlled psychedelic studiesReligion Brain & Behavior · 2026-03-30 Trip sitting or just sitting? Session facilitators substantially influence psychedelic experiences in clinical trials but not in healthy onesPsychiatry Research · 2026-02-12 Challenges with clinical trial participants in studies with classical psychedelics: A position statement from the National Network of Depression Centers’ task group on psychedelics and related compoundsJournal of Psychopharmacology · 2026-02-04 Design, Synthesis, and Pharmacokinetic Profiling of Fluorinated Reversible N -Alkyl Carbamate Derivatives of Psilocin for Sub-Hallucinogenic Brain ExposureJournal of Medicinal Chemistry · 2026-01-25 Daily Administration of Psilocin Mucate (L-130) Produces a Favorable Safety Profile and Anxiolytic Effects in Rodents Exposed to Chronic Unpredictable Mild StressJournal of Psychoactive Drugs · 2026-01-01 Assessing The Readiness of Psychiatrists in Louisiana to Incorporate Psilocybin into Clinical Practice-Lessons Learned from a State Underrepresented in Clinical Psychedelic ResearchPsychedelic Medicine · 2025-12-18 Real-world use of classic and non-classic psychedelics in Hispanic/Latino adults with Obsessive-Compulsive Disorder: International findings from the LATINO Study.UNC Libraries · 2025-10-08 Emerging mechanisms of psilocybin-induced neuroplasticity.Unknown journal · 2025-09-14 Five-year outcomes of psilocybin-assisted therapy for Major Depressive DisorderJournal of Psychedelic Studies · 2025-09-03 FRI-407 Adding the serotonergic agonist psilocybin to semaglutide as a novel combination therapy to cure MASLDJournal of Hepatology · 2025-04-30 Selective outcome reporting and non-reporting in trials of psychedelic drugs for mental disordersEuropean Psychiatry · 2025-03-31 Beneficial effect of the combination psilocybin-semaglutide in a murine model of Steatotic Liver DiseaseDigestive and Liver Disease · 2025-01-31 Direct effects of psilocybin on serotonin receptors regulate lipid accumulation in hepatic cells and adipocytesDigestive and Liver Disease · 2025-01-31 Neurochemical characterization of 5-HT2A R partial agonists with simultaneous PET-MRIJournal of Cerebral Blood Flow & Metabolism · 2024-11-28 Psilocybin alters the circulating metabolomic profile in both non-clinical and clinical modelsBrain Behavior and Immunity · 2024-10-31 Acute Effects of Psilocybin and Salvinorin-A on Functional ConnectivityProceedings on CD-ROM - International Society for Magnetic Resonance in Medicine. Scientific Meeting and Exhibition/Proceedings of the International Society for Magnetic Resonance in Medicine, Scientific Meeting and Exhibition · 2024-08-13 Acute Psychedelic Effects and Clinical Outcomes are Associated With Therapeutic Alliance Among Participants Receiving Psilocybin TherapyDrug and Alcohol Dependence · 2024-06-30 Acute Effects of Hallucinogens on Functional Connectivity: Psilocybin and Salvinorin-AACS Chemical Neuroscience · 2024-06-24 THU-285 Lownonpsychedelic dosed of psilocybin for the therapy of MASLDJournal of Hepatology · 2024-05-31 The therapeutic alliance between study participants and intervention facilitators is associated with acute effects and clinical outcomes in a psilocybin-assisted therapy trial for major depressive disorderPLoS ONE · 2024-03-13 Impact of Psilocybin on Peripheral Cytokine ProductionPsychedelic Medicine · 2024-02-27 Non-psychedelic doses of psilocybin as a novel therapeutic approach for MASLDDigestive and Liver Disease · 2024-01-31 Assessment of the acute subjective psychedelic experience: A review of patient-reported outcome measures in clinical research on classical psychedelics.Unknown journal · 2023-11-15 An open-label pilot trial assessing tolerability and feasibility of LSD microdosing in patients with major depressive disorder (LSDDEP1)Pilot and Feasibility Studies · 2023-10-04 Naturalistic psilocybin use is associated with persisting improvements in mental health and wellbeing: results from a prospective, longitudinal surveyFrontiers in Psychiatry · 2023-09-18 Risk of bias in randomized clinical trials on psychedelic medicine: A systematic review.Unknown journal · 2023-07-03 Changes in synaptic markers after administration of ketamine or psychedelics: a systematic scoping reviewFrontiers in Psychiatry · 2023-06-25 Psychedelics promote plasticity by directly binding to BDNF receptor TrkBNature Neuroscience · 2023-05-31 Psychedelics for Medicinal Use: How Will This Alter the Collective Laboratory Consciousness?Clinical Chemistry · 2023-03-06 Personal Psychedelic Use Is Common Among a Sample of Psychedelic Therapists: Implications for Research and PracticePsychedelic Medicine · 2023-02-15 Behavioral effects of a 14-day repeated treatment with psilocybin at a low non-psychedelic dose: a preliminary study in C57BL/6J miceNeuroscience Applied · 2022-12-31 Single-Dose Psilocybin for a Treatment-Resistant Episode of Major Depression.New England Journal of Medicine · 2022-10-31 Skepticism about Recent Evidence That Psilocybin "Liberates" Depressed Minds.ACS Chemical Neuroscience · 2022-08-23 Psilocybin induces spatially constrained alterations in thalamic functional organizaton and connectivity.NeuroImage · 2022-07-01 Magic mushroom extracts in lipid membranes.Biochimica et Biophysica Acta (BBA) - Biomembranes · 2022-05-09 Models of psychedelic drug action: modulation of cortical-subcortical circuits.Brain · 2022-03-31 Efficacy and safety of psilocybin-assisted treatment for major depressive disorder: Prospective 12-month follow-up.Journal of Psychopharmacology · 2022-01-31 Human Cortical Serotonin 2A Receptor Occupancy by Psilocybin Measured Using [11C]MDL100,907 Dynamic PET and a Resting-State fMRI-Based Brain Parcellation.Frontiers in Neuroergonomics · 2022-01-19 P.0353 Study protocol: psilocybin as a treatment for anorexia nervosa: a pilot studyEuropean Neuropsychopharmacology · 2021-11-30 Psilocybin-assisted therapy for the treatment of resistant major depressive disorder (PsiDeR): protocol for a randomised, placebo-controlled feasibility trial.BMJ Open · 2021-11-30 Psilocybin therapy increases cognitive and neural flexibility in patients with major depressive disorder.Translational Psychiatry · 2021-11-07 Study Protocol for "Psilocybin as a Treatment for Anorexia Nervosa: A Pilot Study".Frontiers in Psychiatry · 2021-10-19 Use of alternative therapy with Psilocybin in oncologic patients with depression and/or anxiety disorders - integrative reviewResearch Society and Development · 2021-08-18 Classic Psychedelic Coadministration with Lithium, but Not Lamotrigine, is Associated with Seizures: An Analysis of Online Psychedelic Experience Reports.Pharmacopsychiatry · 2021-08-03 Optimal dosing for psilocybin pharmacotherapy: Considering weight-adjusted and fixed dosing approaches.Journal of Psychopharmacology · 2021-02-19 Development and Evaluation of a Therapist Training Program for Psilocybin Therapy for Treatment-Resistant Depression in Clinical Research.Frontiers in Psychiatry · 2021-02-02 Development of the Psychological Insight Questionnaire among a sample of people who have consumed psilocybin or LSD.Journal of Psychopharmacology · 2021-01-08 Effects of Psilocybin-Assisted Therapy on Major Depressive DisorderJAMA Psychiatry · 2020-11-03 Psilocybin acutely alters the functional connectivity of the claustrum with brain networks that support perception, memory, and attentionNeuroImage · 2020-05-22 Emotions and brain function are altered up to one month after a single high dose of psilocybinScientific Reports · 2020-02-09 Double-blind comparison of the two hallucinogens psilocybin and dextromethorphan: effects on cognition.Psychopharmacology · 2018-07-29 "Hallucinations" Following Acute Cannabis Dosing: A Case Report and Comparison to Other Hallucinogenic Drugs.Cannabis and Cannabinoid Research · 2018-02-28 Psilocybin-occasioned mystical-type experience in combination with meditation and other spiritual practices produces enduring positive changes in psychological functioning and in trait measures of prosocial attitudes and behaviors.Journal of Psychopharmacology · 2017-10-10 Qualitative and Quantitative Features of Music Reported to Support Peak Mystical Experiences during Psychedelic Therapy Sessions.Frontiers in Psychology · 2017-07-24 Neuroticism is associated with challenging experiences with psilocybin mushrooms.Personality and Individual Differences · 2017-06-06 Psilocybin in long-term meditators: Effects on default mode network functional connectivity and retrospective ratings of qualitative experienceDrug and Alcohol Dependence · 2017-01-20 The Challenging Experience Questionnaire: Characterization of challenging experiences with psilocybin mushrooms.Journal of Psychopharmacology · 2016-11-16 Survey study of challenging experiences after ingesting psilocybin mushrooms: Acute and enduring positive and negative consequences.Journal of Psychopharmacology · 2016-08-29 Validation of the revised mystical experiences questionnaire in experimental sessions with psilocybinDrug and Alcohol Dependence · 2015-10-31 Survey study of challenging experiences after ingesting psilocybin mushrooms: Demographics and phenomenologyDrug and Alcohol Dependence · 2014-12-15 The challenging experience questionnaire: Characterization of acute adverse reactions to psilocybinDrug and Alcohol Dependence · 2014-12-15 Investigation into the temporal stability of aqueous standard solutions of psilocin and psilocybin using high performance liquid chromatography.Science & Justice · 2006-03-31 Psilocin analogs. III. Synthesis of 5-methoxy- and 5-hydroxy-1,2,3,4-tetrahydro-9H-pyrido[3,4-b]indolesJournal of Heterocyclic Chemistry · 1982-06-30 Psilocin analogs II. Synthesis of 3-[2-(dialkylamino)ethyl]-, 3-[2-(N-methyl-N-alkylamino)ethyl]-, and 3-[2-(cycloalkylamino)ethyl]indol-4-olsJournal of Heterocyclic Chemistry · 1980-12-31 Psilocin analogs. 1. Synthesis of 3-[2-(dialkylamino)ethyl] -and 3-[2-(cycloalkylamino)ethyl] indol-4-olsJournal of Heterocyclic Chemistry · 1977-01-31

Author directory